Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 15, Issue 4
Successful novel use of tofacitinib for type II refractory coeliac disease
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Successful novel use of tofacitinib for type II refractory coeliac disease
Online download statistics by month:
Online download statistics by month: April 2022 to March 2023
Abstract
Full
Pdf
Apr 2022
811
21
19
May 2022
788
12
14
Jun 2022
279
10
2
Jul 2022
261
14
5
Aug 2022
87
6
2
Sep 2022
110
7
3
Oct 2022
97
6
5
Nov 2022
241
22
23
Dec 2022
192
36
22
Jan 2023
94
4
3
Feb 2023
127
11
5
Mar 2023
79
7
3
Total
3166
156
106
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF